TY - JOUR
T1 - Variations in the clinical course of submacular hemorrhage
AU - Berrocal, M. H.
AU - Lewis, M. L.
AU - Flynn, Jr
N1 - Funding Information:
Accepted for publication April 24, 1996. From the Department of Ophthalmology, University of Puerto Rico School of Medicine, Rio Piedras, Puerto Rico (Dr. Berrocal); and the Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida (Drs. Lewis and Flynn). This study was supported in part by the Heed Ophthalmic Foundation, Cleveland, Ohio (Dr. Berrocal) and by Research to Prevent Blindness, Inc., New York, New York (Drs. Berrocal, Lewis, and Flynn). Reprint requests to Mary Lou Lewis, M.D., P. O. Box 016880, Miami, FL 33101; fax: (305) 326-6417; E-mail: mlewis® bascom.med.miami.edu
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1996
Y1 - 1996
N2 - Purpose: To assess variations in the clinical course of submacular hemorrhages. Methods: We reviewed fundus photography charts taken of patients during a 27-month period. Thirty-one eyes of 31 patients with submacular hemorrhages under the foveal avascular zone were reviewed. Results: In 20 of the eyes, the underlying etiology was age-related macular degeneration (ARMD). The other 11 eyes had various underlying conditions, including macroaneurysms (two), presumed ocular histoplasmosis syndrome (two), trauma (one), Valsalva's retinopathy (one), idiopathic central serous choroidopathy (one), diabetic retinopathy (two), central retinal vein occlusion (one), and choroidal rupture (one). Of the eyes with ARMD (mean follow-up, 29 months), eight (40%) of 20 showed an improvement in visual acuity (≤2 Snellen lines), six (30%) of 20 had a final visual acuity of 20/80 or better, and three (15%) had a final visual acuity of 20/40 or better (range, 20/25 to 20/80). Of the eyes without ARMD (mean follow-up, 29 months), five (45%) of 11 had an improvement in visual acuity and five(45%) of 11 attained a final visual acuity of 20/40 or better (range, 20/20 to 20/40). The best predictive factor for poor final visual acuity was the presence of a subretinal neovascular membrane. Conclusions: Patients with submacular hemorrhage may have spontaneous improvement in visual acuity without surgery. Patients without subretinal neovascular membranes had a better visual improvement rate.
AB - Purpose: To assess variations in the clinical course of submacular hemorrhages. Methods: We reviewed fundus photography charts taken of patients during a 27-month period. Thirty-one eyes of 31 patients with submacular hemorrhages under the foveal avascular zone were reviewed. Results: In 20 of the eyes, the underlying etiology was age-related macular degeneration (ARMD). The other 11 eyes had various underlying conditions, including macroaneurysms (two), presumed ocular histoplasmosis syndrome (two), trauma (one), Valsalva's retinopathy (one), idiopathic central serous choroidopathy (one), diabetic retinopathy (two), central retinal vein occlusion (one), and choroidal rupture (one). Of the eyes with ARMD (mean follow-up, 29 months), eight (40%) of 20 showed an improvement in visual acuity (≤2 Snellen lines), six (30%) of 20 had a final visual acuity of 20/80 or better, and three (15%) had a final visual acuity of 20/40 or better (range, 20/25 to 20/80). Of the eyes without ARMD (mean follow-up, 29 months), five (45%) of 11 had an improvement in visual acuity and five(45%) of 11 attained a final visual acuity of 20/40 or better (range, 20/20 to 20/40). The best predictive factor for poor final visual acuity was the presence of a subretinal neovascular membrane. Conclusions: Patients with submacular hemorrhage may have spontaneous improvement in visual acuity without surgery. Patients without subretinal neovascular membranes had a better visual improvement rate.
UR - http://www.scopus.com/inward/record.url?scp=0029781944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029781944&partnerID=8YFLogxK
U2 - 10.1016/S0002-9394(14)72107-5
DO - 10.1016/S0002-9394(14)72107-5
M3 - Article
C2 - 8862044
AN - SCOPUS:0029781944
VL - 122
SP - 486
EP - 493
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
SN - 0002-9394
IS - 4
ER -